Sharing Progress in Cancer Care (SPCC) shared a post on LinkedIn:
“The Definitive Trial project is a clinical trial funded by the European Commission, aiming to demonstrate that personalised treatment decisions in early-stage HER2-positive breast cancer, using the HER2DX diagnostic assay, improve quality of life without affecting outcomes or survival.
As part of this initiative, we are now developing the training of health professionals.
The first three webinars are now available on demand on our e-learning platform.
All sessions are CME accredited.”
More posts featuring SPCC.